Marc Grenley

Marc Grenley serves as the Associate Director of Technology Integration at Presage Biosciences, Inc., since March 2010, where a strong focus on translating innovative science into impactful cancer therapies is evident. Areas of expertise include preclinical drug development, particularly in tumor microenvironment dynamics and intratumoral microdosing. Prior to this role, Marc was a Senior Research Associate at the same company, significantly contributing to the development of the CIVO platform for assessing drug effects in various models. Previous experience includes serving as a Research Associate II at Fred Hutchinson Cancer Research under Dr. Phil Soriano. Academic qualifications consist of a Bachelor of Science in Genetics and Cell Biology from Washington State University, a Certificate in Applied BioStatistics from the University of Washington, and coursework in Molecular Biology at Vanderbilt University.